论文部分内容阅读
目的:观察元生胶囊治疗直肠癌术后的临床疗效。方法:将45例直肠癌术后患者随机分为对照组22例和治疗组23例。对照组用FOLFOX4方案化疗,治疗组在单纯化疗的基础上加口服元生胶囊治疗,疗程为2个化疗周期。结果:治疗组显效率、总有效率分别为60.9%、91.3%,对照组分别为36.4%、72.8%,组间比较,差异有统计学意义(P<0.05)。与对照组比较,治疗组能抑制白细胞减少,减轻恶心、呕吐等化疗毒副作用,稳定KPS评分,差异均有统计学意义(P<0.01)。结论:元生胶囊能改善行FOLFOX4方案化疗的直肠癌患者的免疫功能,提高生活质量。
Objective: To observe the clinical efficacy of Yuansheng Capsule in the treatment of postoperative rectal cancer. Methods: Forty-five patients with rectal cancer were randomly divided into control group (n = 22) and treatment group (n = 23). Control group with FOLFOX4 chemotherapy, the treatment group on the basis of chemotherapy alone plus oral Yuan Sheng capsule treatment, the course of treatment for the two cycles of chemotherapy. Results: The effective rate and total effective rate were 60.9% and 91.3% respectively in the treatment group and 36.4% and 72.8% in the control group respectively. There was significant difference between the two groups (P <0.05). Compared with the control group, the treatment group can inhibit leukopenia, reduce the side effects of chemotherapy and nausea, vomiting and other chemical side effects, stable KPS score, the difference was statistically significant (P <0.01). Conclusion: Yuansheng Capsule can improve immune function and improve quality of life in rectal cancer patients undergoing chemotherapy with FOLFOX4 regimen.